When in the treatment continuum to use PARP inhibition in ovarian cancer

Mansoor Raza Mirza

When in the treatment continuum to use PARP inhibition in ovarian cancer

Afdeling for Kræftbehandling

1 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Clinical Advances in Hematology and Oncology
Vol/bind	19
Udgave nummer	2
Sider (fra-til)	84-86
Antal sider	3
ISSN	1543-0790
Status	Udgivet - feb. 2021

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{c21b14522d5d40e0b696b42748c04121,

title = "When in the treatment continuum to use PARP inhibition in ovarian cancer",

keywords = "Antineoplastic Combined Chemotherapy Protocols/adverse effects, Biomarkers, Tumor, Carcinoma, Ovarian Epithelial/drug therapy, Drug Administration Schedule, Drugs, Investigational/administration & dosage, Female, Humans, Ovarian Neoplasms/drug therapy, Poly(ADP-ribose) Polymerase Inhibitors/administration & dosage, Practice Patterns, Physicians', Recurrence, Remission Induction, Salvage Therapy, Treatment Outcome",

author = "Mirza, {Mansoor Raza}",

year = "2021",

month = feb,

language = "English",

volume = "19",

pages = "84--86",

journal = "Clinical Advances in Hematology and Oncology",

issn = "1543-0790",

publisher = "Millennium Medical Publishing, Inc",

number = "2",

}

TY - JOUR

T1 - When in the treatment continuum to use PARP inhibition in ovarian cancer

AU - Mirza, Mansoor Raza

PY - 2021/2

Y1 - 2021/2

KW - Antineoplastic Combined Chemotherapy Protocols/adverse effects

KW - Biomarkers, Tumor

KW - Carcinoma, Ovarian Epithelial/drug therapy

KW - Drug Administration Schedule

KW - Drugs, Investigational/administration & dosage

KW - Female

KW - Humans

KW - Ovarian Neoplasms/drug therapy

KW - Poly(ADP-ribose) Polymerase Inhibitors/administration & dosage

KW - Practice Patterns, Physicians'

KW - Recurrence

KW - Remission Induction

KW - Salvage Therapy

KW - Treatment Outcome

UR - http://www.scopus.com/inward/record.url?scp=85101270644&partnerID=8YFLogxK

M3 - Journal article

C2 - 33596189

SN - 1543-0790

VL - 19

SP - 84

EP - 86

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

IS - 2

ER -